{"id":"NCT01882647","sponsor":"Therapeutics, Inc.","briefTitle":"A Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)","officialTitle":"A Multicenter, Randomized, Double-Blind, Parallel Group Comparison of 000-0551 Lotion Versus Vehicle Lotion in Subjects With Plaque Psoriasis (Study -305)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-06","primaryCompletion":"2014-03","completion":"2014-03","firstPosted":"2013-06-20","resultsPosted":"2017-02-13","lastUpdate":"2017-02-13"},"enrollment":222,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Plaque Psoriasis"],"interventions":[{"type":"DRUG","name":"000-0551 Lotion","otherNames":[]},{"type":"DRUG","name":"Vehicle Lotion","otherNames":[]}],"arms":[{"label":"Active Arm","type":"EXPERIMENTAL"},{"label":"Vehicle Arm","type":"PLACEBO_COMPARATOR"}],"summary":"This Phase 3 study has been designed to determine and compare the efficacy and safety of 000-0551 Lotion and Vehicle Lotion applied twice daily for two weeks in subjects with plaque psoriasis.","primaryOutcome":{"measure":"The Percentage of Subjects Rated a \"Treatment Success\" Based on the Investigator's Global Assessment (IGA)","timeFrame":"Day 15","effectByArm":[{"arm":"Active Arm","deltaMin":44.5,"sd":null},{"arm":"Vehicle Arm","deltaMin":7.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"<0.001"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":11,"countries":["United States"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":110},"commonTop":["Application site pain","Headache","Diarrhoea","Nausea","Bowel movement irregularity"]}}